EpiBiologics
PrivateLast Round
Series B
Jan 8, 2026
Total Funding Raised
$287M
Momentum Score
25 /100
Company Overview
EpiBiologics is a biotechnology company that develops protein degradation therapeutics aimed at addressing the root causes of disease biology through antibody-based targeted therapies.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EpiBiologics Comps
Public and private peers based on sector, stage, and business model.
EpiBiologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 8, 2026 | ||||
| Series B | Jan 8, 2024 | ||||
| Series A Extension | Jul 20, 2023 | ||||
| Series A | Mar 22, 2023 |
Key People
Founding team and executive leadership
EpiBiologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Codon Capital | Series B, Series A Extension |
| GV | Series B, Series A Extension, Series A |
| Digitalis Ventures | Series B, Series A Extension |
| Taiho Ventures | Series B, Series A Extension |
| Avego BioScience Capital | Series B |
| Novartis Venture Fund | Series B |
| Mubadala Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2026
Developing an experimental protein-destroying antibody for clinical trials.
- Jan 8, 2024
$107M round raised
EpiBiologics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EpiBiologics's valuation, stock price, and market status.
